As part of a feasibility study, Royal Adelaide Hospital in South Australia has performed the first procedure using St. Jude Medical’s renal denervation catheter and generator system to treat resistant hypertension.
The design of the new catheter minimises the need for extensive catheter manipulation, which could potentially shorten procedure times, limit contrast use and reduce fluoroscopic exposure.
St. Jude Medical Cardiovascular Division president Frank Callaghan said the new technology could potentially benefit patients through an overall reduction in risks for cardiovascular side effects of hypertension, including death.
"We have leveraged our company’s extensive experience in ablation technologies to develop a renal denervation system that provides physicians with an alternative therapeutic option for patients with resistant hypertension,” Callaghan said.
The company expects a limited market launch in Europe before the end of 2012.